GlassScriptPhysician profile
Travis D Klatt
NPI 1104223635
$5,695.46
in general payments reported to CMS, 2019-2025
10 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,030 · 2020: $2,523 · 2021: $229 · 2022: $85.23 · 2023: $119 · 2024: $1,548 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,107 · Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,107.07 |
| Food and Beverage | $721.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Medical LLC | $3,537.80 | 2019-2021 | |
| Foundation Medical, LLC | $919.02 | 2023-2025 | |
| Arthrex, INC. | $451.35 | 2024 | |
| Treace Medical Concepts, INC. | $280.85 | 2023-2024 | |
| Orthofix Medical, INC. | $172.79 | 2020-2025 | Physio-Stim |
| Smith+Nephew, INC. | $129.45 | 2021-2025 | Collagenase Santyl |
| Organogenesis INC. | $89.06 | 2021-2022 | |
| Paragon 28, INC. | $63.89 | 2020-2024 | Bun-Yo-Matic |
| Paratek Pharmaceuticals, INC. | $30.83 | 2025 | Nuzyra |
| Urgo Medical North America, LLC | $20.42 | 2024 | Urgok2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Klatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.